In this webcast, experts will discuss the results of Onyx ONE, the clinical implications of the results, duration of antiplatelet therapy for HBR patients, and the follow-up study in patients with HBR.
In this webcast, a panel of experts will discuss the clinical implications of the trial results, discuss the optimal patient characteristics who will benefit and the importance of including heart failure specialists and imagers to optimize patient outcomes.
This program examines the evidence for use of aspirin by the inverventionalist, with evidence-based discussion of clinical risks and benefits of aspirin use in various clinical contexts.
In this program participants will learn about valve durability, treating bicuspid patients, and advanced valve-in-valve concepts. Expert panelists also discuss recent clinical trial data.
This interactive program, led by expert faculty members, covers TMVR clinical trial design, appropriate patient selection and screening, and optimal care.
This webcast discussion will move beyond high-risk patients and explore the new boundaries of transcatheter therapy. Participants will learn from discussions about considerations for low-risk patient populations, treatment decision making, and recent clinical trial data.
